Cargando…
Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer
BACKGROUND: Breast cancer (BC) is the most frequent tumour in women. Triple negative tumours (TNBC)–which are associated with minor survival rates—lack markers predictive of response to anticancer drugs. Triple negative tumours frequently metastasise to the central nervous system (CNS). OBJECTIVE: T...
Autores principales: | Rojas L, Katerin, Trilla-Fuertes, Lucía, Gámez-Pozo, Angelo, Chiva, Cristina, Sepúlveda, Juan, Manso, Luis, Prado-Vázquez, Guillermo, Zapater-Moros, Andrea, López-Vacas, Rocío, Ferrer-Gómez, María, Mendiola, César, Espinosa, Enrique, Sabidó, Eduard, Ciruelos, Eva, Vara, Juan Ángel Fresno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369972/ https://www.ncbi.nlm.nih.gov/pubmed/30792808 http://dx.doi.org/10.3332/ecancer.2019.891 |
Ejemplares similares
-
Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases
por: Laimito, Katerin Rojas, et al.
Publicado: (2016) -
Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics
por: Gámez-Pozo, Angelo, et al.
Publicado: (2017) -
Melanoma proteomics suggests functional differences related to mutational status
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2019) -
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
por: Prado-Vázquez, Guillermo, et al.
Publicado: (2019) -
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020)